Tumour necrosis factor-α induces hyperreactivity in tracheal smooth muscle of the guinea-pig in vitro

European Respiratory Journal

Volumn 12, Issue 1, 1998, Pages 45-49

  Pennings, H J ^a   Kramer, K ^b   Bast, A ^b   Buurmam, W A ^c   Wouters, E F M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Airway smooth muscle; Bronchial hyperresponsiveness; Platelet activating factor; Tumor necrosis factor

Indexed keywords

APAFANT; INDOMETACIN; METHACHOLINE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; GUINEA PIG; IN VITRO STUDY; MEDIATOR RELEASE; MUSCLE ISOTONIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; TRACHEA;

AIRWAY RESISTANCE; ANIMALS; AZEPINES; BRONCHIAL HYPERREACTIVITY; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; INDOMETHACIN; MUSCLE, SMOOTH; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; RECOMBINANT PROTEINS; TRIAZOLES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031816128     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12010045     Document Type: Article

References (32)

1. Clark TJH, Godfrey S, Lee TH. Asthma. London, Chapman & Hall, 3rd Edn, 1992; pp. 108-132.
2. Michel O, Ginanni R, Le Bon B, Content J, Duchateau J, Sergysels R. Inflammatory response to acute inhalation of endotoxin in asthmatic patients. Am Rev Respir Dis 1992; 146: 352-357.
3. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481-1486.
4. Kips JC, Tavernier J, Pauwels RA. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis 1992; 145: 332-336.
5. Virchow JC, Walker C, Hafner D, et al. T-cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995; 151: 960-968.
6. Keatings VM, O'Connor BJ, Wright LG, Huston DP, Corrigan CJ, Barnes PJ. Late response to allergen is associated with increased concentrations of tumor necrosis factor-α and IL-5 in induced sputum. J Allergy Clin Immunol 1997; 99: 693-698.
7. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992; 89: 958-967.
8. Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S. Detection of cytokines and their cell sources in bronchial biopy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest 1994; 105: 687-696.
9. Maestrelli P, Di Stefano A, Occari P, et al. Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate. Am J Respir Crit Care Med 1995; 151: 607-612.
10. Thomas WS, Yates DH, Barnes PJ. Tumor necrosis factor-α increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995; 152: 76-80.
11. Beutler B, Cerami A. The biology of cachectin/TNF-α primary mediator of the host response. Am Rev Immunol 1989; 7: 625-655.
12. Cembrzynska-Nowak M, Sklarz E, Inglot AD, Teodorczyk-Injeyan JA. Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leucocytes from patients with bronchial asthma. Am Rev Respir Dis 1993; 147: 291-295.
13. Ohkawara Y, Yamauchi K, Tanno Y, et al. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-α in sensitized lung tissue after IgE receptor triggering. Am J Respir Cell Mol Biol 1992; 7: 385-392.
14. Robinson DS, Hamid Q, Sun Y, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.
15. Mohler KM, Torrance DS, Smith CA, et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993; 151: 1548-1561.
16. Weber KH, Heuer H. Structure-activity relationships and effects of platelet-activating factor antagonists in the hetrazepine series, Int Arch Allergy Appl Immunol 1989; 88: 82-87.
17. Kramer K, Doelman CJA, Timmerman H, Bast A. A disbalance between beta-adrenergic and muscarinic responses caused by hydrogen peroxide in rat airways in vitro. Biochem Biophys Res Commun 1987; 145: 357-362.
18. 2 activation in human neutrophils. An alternative mechanism of priming. J Immunol 1991; 146: 1277-1285.
19. Brunelleschi S, Renzi D, Ledda F, et al. Interference of WEB 2086 and BN 52021 with PAF-induced effects on guinea-pig trachea. Br J Pharmacol 1989; 97: 469-474.
20. Wills-Karp M, Uchida Y, Lee JY, Jinot J, Hirata A, Hirata F. Organ culture with proinflammatory cytokines reproduces impairment of the β-adrenoceptor-mediated relaxation in tracheas of a guinea pig antigen model. Am J Respir Cell Mol Biol 1983; 8: 153-159.
21. Anticevich SZ, Hughes JM, Black JL, Armour CL. Induction of human airway hyperresponsiveness by tumour necrosis factor-α. Eur J Pharmacol 1995; 284: 221-225.
22. Camussi G, Bussolino F, Salvidio G, Baglioni C. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 1987; 166: 1390-1404.
23. Mazzoni L, Morley J, Page CP, Sanjar S. Induction of airway-hyperreactivity by platelet-activating factor in the guinea pig. J Physiol 1985; 365: 107P.
24. Robertson DN, Coyle AJ, Rhoden KJ, Grandordy B, Page CP, Barnes PJ. The effect of platelet-activating factor on histamine and muscarinic receptor function in guinea pig airways. Am Rev Respir Dis 1988; 137: 1317-1322.
25. Shelhaemer JH, Levine SJ, Tong Wu, Jacoby DB, Kaliner MA, Rennard SI. Airway inflammation. Ann Int Med 1995; 123: 288-304.
26. Valone FH, Epstein LB. Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1β, tumor necrosis factor or IFN-γ. J Immunol 1988; 141: 3945-3950.
27. Tomlinson PR, Croft K, Harris T, Stewart AG. Platelet-activating factor biosynthesis in rat vascular smooth muscle cells. J Vase Res 1994; 31: 144-152.
28. Amrani Y, Bronner C. Tumor necrosis factor alpha potentiates the increase in cytosolic free calcium induced by bradykinin in guinea-pig tracheal smooth muscle cells. C R Acad Sci Paris 1993 ; 316: 1489-1494.
29. Jeanneton O, Delvaux M, Botella A, Frexinos J, Bueno L. Platelet-activating factor (PAF) induces a contraction of isolated smooth muscle cells from guinea pig ileum: intracellular pathway involved. J Pharmacol Exp Ther 1993; 267: 31-37.
30. Hozawa S, Haruta Y, Ishioka S, Yamakido M. Effects of a PAF-antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. Am J Respir Crit Care Med 1995; 152: 1198-1202.
31. Stafforini DM, Satoh K, Atkinson DL, et al. Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest 1996: 97: 2784-2791.
32. Renzetti LM, Paciorek PM, Tannu SA, et al. Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways. J Pharmacol Exp Ther 1996; 278: 847-853.